1	Transient	transient	_	_	_	_	_	_	_
2	pseudo-hypoaldosteronism	pseudo-hypoaldosteronism	_	_	_	_	_	_	_
3	following	follow	_	_	_	_	_	_	_
4	resection	resection	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	ileum	ileum	_	_	_	_	_	_	_
8	:	:	_	_	_	_	_	_	_
9	normal	normal	_	_	_	_	_	_	_
10	level	level	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	lymphocytic	lymphocytic	_	_	_	_	_	_	_
13	aldosterone	aldosterone	_	_	_	_	_	_	_
14	receptors	receptor	_	_	_	_	_	_	_
15	outside	outside	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	acute	acute	_	_	_	_	_	_	_
18	phase	phase	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Pseudo-hypoaldosteronism	Pseudo-hypoaldosteronism	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	PHA	PHA	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	due	due	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	mineralocorticoid	mineralocorticoid	_	_	_	_	_	_	_
9	resistance	resistance	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	manifests	manifest	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	hyponatremia	hyponatremia	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	hyperkalemia	hyperkalemia	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	increased	increase	_	_	_	_	_	_	_
18	plasma	plasma	_	_	_	_	_	_	_
19	aldosterone	aldosterone	_	_	_	_	_	_	_
20	levels	level	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	may	may	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	familial	familial	_	_	_	_	_	_	_
5	or	or	_	_	_	_	_	_	_
6	secondary	secondary	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	abnormal	abnormal	_	_	_	_	_	_	_
9	renal	renal	_	_	_	_	_	_	_
10	sodium	sodium	_	_	_	_	_	_	_
11	handling	handling	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	report	report	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	case	case	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	54-year-old	54-year-old	_	_	_	_	_	_	_
8	woman	woman	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	multifocal	multifocal	_	_	_	_	_	_	_
11	cancer	cancer	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	colon	colon	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	who	who	_	_	_	_	_	_	_
17	developed	develop	_	_	_	_	_	_	_
18	PHA	PHA	_	_	_	_	_	_	_
19	after	after	_	_	_	_	_	_	_
20	subtotal	subtotal	_	_	_	_	_	_	_
21	colectomy	colectomy	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	ileal	ileal	_	_	_	_	_	_	_
24	resection	resection	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	jejunostomy	jejunostomy	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	She	she	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	treated	treat	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	6	6	_	_	_	_	_	_	_
6	g	g	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	salt	salt	_	_	_	_	_	_	_
9	daily	daily	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	prevent	prevent	_	_	_	_	_	_	_
12	dehydration	dehydration	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	which	which	_	_	_	_	_	_	_
15	she	she	_	_	_	_	_	_	_
16	stopped	stop	_	_	_	_	_	_	_
17	herself	herself	_	_	_	_	_	_	_
18	because	because	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	reduced	reduce	_	_	_	_	_	_	_
21	fecal	fecal	_	_	_	_	_	_	_
22	losses	loss	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	month	month	_	_	_	_	_	_	_
3	later	later	_	_	_	_	_	_	_
4	she	she	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	admitted	admit	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	signs	sign	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	acute	acute	_	_	_	_	_	_	_
11	adrenal	adrenal	_	_	_	_	_	_	_
12	failure	failure	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	i.e.	i.e.	_	_	_	_	_	_	_
15	fatigue	fatigue	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	severe	severe	_	_	_	_	_	_	_
18	nausea	nausea	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	blood	blood	_	_	_	_	_	_	_
21	pressure	pressure	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	80/60	80/60	_	_	_	_	_	_	_
24	mmHg	mmhg	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	extracellular	extracellular	_	_	_	_	_	_	_
27	dehydration	dehydration	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	hyponatremia	hyponatremia	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	118	118	_	_	_	_	_	_	_
32	mmol/l	mmol/l	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	;	;	_	_	_	_	_	_	_
35	hyperkalemia	hyperkalemia	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	7.6	7.6	_	_	_	_	_	_	_
38	mmol/l	mmol/l	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	increased	increase	_	_	_	_	_	_	_
42	blood	blood	_	_	_	_	_	_	_
43	urea	urea	_	_	_	_	_	_	_
44	nitrogen	nitrogen	_	_	_	_	_	_	_
45	(	(	_	_	_	_	_	_	_
46	BUN	BUN	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	(	(	_	_	_	_	_	_	_
49	200	200	_	_	_	_	_	_	_
50	mg/dl	mg/dl	_	_	_	_	_	_	_
51	)	)	_	_	_	_	_	_	_
52	and	and	_	_	_	_	_	_	_
53	creatininemia	creatininemia	_	_	_	_	_	_	_
54	(	(	_	_	_	_	_	_	_
55	2.5	2.5	_	_	_	_	_	_	_
56	mg/dl	mg/dl	_	_	_	_	_	_	_
57	)	)	_	_	_	_	_	_	_
58	,	,	_	_	_	_	_	_	_
59	and	and	_	_	_	_	_	_	_
60	decreased	decrease	_	_	_	_	_	_	_
61	plasma	plasma	_	_	_	_	_	_	_
62	bicarbonates	bicarbonate	_	_	_	_	_	_	_
63	level	level	_	_	_	_	_	_	_
64	(	(	_	_	_	_	_	_	_
65	HCO3-	HCO3-	_	_	_	_	_	_	_
66	:	:	_	_	_	_	_	_	_
67	16	16	_	_	_	_	_	_	_
68	mmol/l	mmol/l	_	_	_	_	_	_	_
69	;	;	_	_	_	_	_	_	_
70	N	N	_	_	_	_	_	_	_
71	:	:	_	_	_	_	_	_	_
72	27-30	27-30	_	_	_	_	_	_	_
73	)	)	_	_	_	_	_	_	_
74	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	plasma	plasma	_	_	_	_	_	_	_
5	cortisol	cortisol	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	high	high	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	66	66	_	_	_	_	_	_	_
10	microg/100	microg/100	_	_	_	_	_	_	_
11	ml	ml	_	_	_	_	_	_	_
12	at	at	_	_	_	_	_	_	_
13	10:00	10:00	_	_	_	_	_	_	_
14	h	h	_	_	_	_	_	_	_
15	;	;	_	_	_	_	_	_	_
16	N	N	_	_	_	_	_	_	_
17	:	:	_	_	_	_	_	_	_
18	8-15	8-15	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	ACTH	acth	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	normal	normal	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	13	13	_	_	_	_	_	_	_
27	pg/ml	pg/ml	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	N	N	_	_	_	_	_	_	_
30	:	:	_	_	_	_	_	_	_
31	10-60	10-60	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	;	;	_	_	_	_	_	_	_
34	there	there	_	_	_	_	_	_	_
35	was	be	_	_	_	_	_	_	_
36	a	a	_	_	_	_	_	_	_
37	marked	marked	_	_	_	_	_	_	_
38	increase	increase	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	plasma	plasma	_	_	_	_	_	_	_
41	renin	renin	_	_	_	_	_	_	_
42	activity	activity	_	_	_	_	_	_	_
43	(	(	_	_	_	_	_	_	_
44	>37	>37	_	_	_	_	_	_	_
45	ng/ml/h	ng/ml/h	_	_	_	_	_	_	_
46	;	;	_	_	_	_	_	_	_
47	N	N	_	_	_	_	_	_	_
48	supine	supine	_	_	_	_	_	_	_
49	<3	<3	_	_	_	_	_	_	_
50	)	)	_	_	_	_	_	_	_
51	,	,	_	_	_	_	_	_	_
52	active	active	_	_	_	_	_	_	_
53	renin	renin	_	_	_	_	_	_	_
54	(	(	_	_	_	_	_	_	_
55	869	869	_	_	_	_	_	_	_
56	pg/ml	pg/ml	_	_	_	_	_	_	_
57	;	;	_	_	_	_	_	_	_
58	N	N	_	_	_	_	_	_	_
59	supine	supine	_	_	_	_	_	_	_
60	:	:	_	_	_	_	_	_	_
61	1.120	1.120	_	_	_	_	_	_	_
62	)	)	_	_	_	_	_	_	_
63	,	,	_	_	_	_	_	_	_
64	aldosterone	aldosterone	_	_	_	_	_	_	_
65	(	(	_	_	_	_	_	_	_
66	>2000	>2000	_	_	_	_	_	_	_
67	pg/ml	pg/ml	_	_	_	_	_	_	_
68	;	;	_	_	_	_	_	_	_
69	N	N	_	_	_	_	_	_	_
70	supine	supine	_	_	_	_	_	_	_
71	<150	<150	_	_	_	_	_	_	_
72	)	)	_	_	_	_	_	_	_
73	and	and	_	_	_	_	_	_	_
74	plasma	plasma	_	_	_	_	_	_	_
75	AVP	AVP	_	_	_	_	_	_	_
76	(	(	_	_	_	_	_	_	_
77	20	20	_	_	_	_	_	_	_
78	pmol/l	pmol/l	_	_	_	_	_	_	_
79	;	;	_	_	_	_	_	_	_
80	N	N	_	_	_	_	_	_	_
81	:	:	_	_	_	_	_	_	_
82	0.5-2.5	0.5-2.5	_	_	_	_	_	_	_
83	)	)	_	_	_	_	_	_	_
84	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	plasma	plasma	_	_	_	_	_	_	_
3	ANH	ANH	_	_	_	_	_	_	_
4	level	level	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	38	38	_	_	_	_	_	_	_
7	pmol/l	pmol/l	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	N	N	_	_	_	_	_	_	_
10	supine	supine	_	_	_	_	_	_	_
11	:	:	_	_	_	_	_	_	_
12	5-25	5-25	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	urinary	urinary	_	_	_	_	_	_	_
3	steroidogram	steroidogram	_	_	_	_	_	_	_
4	resulted	result	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	highly	highly	_	_	_	_	_	_	_
7	elevated	elevated	_	_	_	_	_	_	_
8	tetrahydrocortisol	tetrahydrocortisol	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	THF	THF	_	_	_	_	_	_	_
11	:	:	_	_	_	_	_	_	_
12	13.3	13.3	_	_	_	_	_	_	_
13	mg/24h	mg/24h	_	_	_	_	_	_	_
14	;	;	_	_	_	_	_	_	_
15	N	N	_	_	_	_	_	_	_
16	:	:	_	_	_	_	_	_	_
17	1.4+/-0.8	1.4+/-0.8	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	no	no	_	_	_	_	_	_	_
21	increase	increase	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	tetrahydrocortisone	tetrahydrocortisone	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	THE	the	_	_	_	_	_	_	_
26	:	:	_	_	_	_	_	_	_
27	3.16	3.16	_	_	_	_	_	_	_
28	mg/24h	mg/24h	_	_	_	_	_	_	_
29	;	;	_	_	_	_	_	_	_
30	N	N	_	_	_	_	_	_	_
31	:	:	_	_	_	_	_	_	_
32	2.7+/-2.0	2.7+/-2.0	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	excretion	excretion	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	with	with	_	_	_	_	_	_	_
38	low	low	_	_	_	_	_	_	_
39	THE/THF	THE/THF	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	0.24	0.24	_	_	_	_	_	_	_
42	;	;	_	_	_	_	_	_	_
43	N	N	_	_	_	_	_	_	_
44	:	:	_	_	_	_	_	_	_
45	1.87+/-0.36	1.87+/-0.36	_	_	_	_	_	_	_
46	)	)	_	_	_	_	_	_	_
47	and	and	_	_	_	_	_	_	_
48	alpha	alpha	_	_	_	_	_	_	_
49	THF/THF	thf/thf	_	_	_	_	_	_	_
50	(	(	_	_	_	_	_	_	_
51	0.35	0.35	_	_	_	_	_	_	_
52	;	;	_	_	_	_	_	_	_
53	N	N	_	_	_	_	_	_	_
54	:	:	_	_	_	_	_	_	_
55	0.92+/-0.42	0.92+/-0.42	_	_	_	_	_	_	_
56	)	)	_	_	_	_	_	_	_
57	ratios	ratio	_	_	_	_	_	_	_
58	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	number	number	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	mineralocorticoid	mineralocorticoid	_	_	_	_	_	_	_
5	receptors	receptor	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	mononuclear	mononuclear	_	_	_	_	_	_	_
8	leukocytes	leukocyte	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	lower	low	_	_	_	_	_	_	_
13	normal	normal	_	_	_	_	_	_	_
14	range	range	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	age	age	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	while	while	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	number	number	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
23	receptors	receptor	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	reduced	reduce	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Small-bowel	small-bowel	_	_	_	_	_	_	_
2	resection	resection	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	ileostomized	ileostomized	_	_	_	_	_	_	_
5	patients	patient	_	_	_	_	_	_	_
6	causes	cause	_	_	_	_	_	_	_
7	excessive	excessive	_	_	_	_	_	_	_
8	fecal	fecal	_	_	_	_	_	_	_
9	sodium	sodium	_	_	_	_	_	_	_
10	losses	loss	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	results	result	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	chronic	chronic	_	_	_	_	_	_	_
15	sodium	sodium	_	_	_	_	_	_	_
16	depletion	depletion	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	contraction	contraction	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	plasma	plasma	_	_	_	_	_	_	_
22	volume	volume	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	severe	severe	_	_	_	_	_	_	_
25	secondary	secondary	_	_	_	_	_	_	_
26	hyperaldosteronism	hyperaldosteronism	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Nevertheless	nevertheless	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	hyperaldosteronism	hyperaldosteronism	_	_	_	_	_	_	_
5	may	may	_	_	_	_	_	_	_
6	be	be	_	_	_	_	_	_	_
7	associated	associate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	hyponatremia	hyponatremia	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	hyperkalemia	hyperkalemia	_	_	_	_	_	_	_
12	suggesting	suggest	_	_	_	_	_	_	_
13	PHA	PHA	_	_	_	_	_	_	_
14	related	related	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	major	major	_	_	_	_	_	_	_
18	importance	importance	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	colon	colon	_	_	_	_	_	_	_
22	for	for	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	absorption	absorption	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	sodium	sodium	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	conclusion	conclusion	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	case	case	_	_	_	_	_	_	_
6	report	report	_	_	_	_	_	_	_
7	emphasizes	emphasize	_	_	_	_	_	_	_
8	1	1	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	possibility	possibility	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	syndrome	syndrome	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	acquired	acquire	_	_	_	_	_	_	_
17	PHA	PHA	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	severe	severe	_	_	_	_	_	_	_
20	hyperkalemia	hyperkalemia	_	_	_	_	_	_	_
21	after	after	_	_	_	_	_	_	_
22	resection	resection	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	ileum	ileum	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	colon	colon	_	_	_	_	_	_	_
28	responding	respond	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	oral	oral	_	_	_	_	_	_	_
31	salt	salt	_	_	_	_	_	_	_
32	supplementation	supplementation	_	_	_	_	_	_	_
33	;	;	_	_	_	_	_	_	_
34	2	2	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	major	major	_	_	_	_	_	_	_
38	increase	increase	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	AVP	AVP	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	the	the	_	_	_	_	_	_	_
43	small	small	_	_	_	_	_	_	_
44	increase	increase	_	_	_	_	_	_	_
45	in	in	_	_	_	_	_	_	_
46	ANH	ANH	_	_	_	_	_	_	_
47	;	;	_	_	_	_	_	_	_
48	3	3	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	the	the	_	_	_	_	_	_	_
51	strong	strong	_	_	_	_	_	_	_
52	increase	increase	_	_	_	_	_	_	_
53	in	in	_	_	_	_	_	_	_
54	urinary	urinary	_	_	_	_	_	_	_
55	THF	thf	_	_	_	_	_	_	_
56	with	with	_	_	_	_	_	_	_
57	low	low	_	_	_	_	_	_	_
58	THE/THF	the/thf	_	_	_	_	_	_	_
59	and	and	_	_	_	_	_	_	_
60	alpha	alpha	_	_	_	_	_	_	_
61	THF/THF	thf/thf	_	_	_	_	_	_	_
62	ratios	ratio	_	_	_	_	_	_	_
63	;	;	_	_	_	_	_	_	_
64	4	4	_	_	_	_	_	_	_
65	)	)	_	_	_	_	_	_	_
66	the	the	_	_	_	_	_	_	_
67	normal	normal	_	_	_	_	_	_	_
68	number	number	_	_	_	_	_	_	_
69	of	of	_	_	_	_	_	_	_
70	lymphocytic	lymphocytic	_	_	_	_	_	_	_
71	mineralocorticoid	mineralocorticoid	_	_	_	_	_	_	_
72	receptors	receptor	_	_	_	_	_	_	_
73	outside	outside	_	_	_	_	_	_	_
74	the	the	_	_	_	_	_	_	_
75	acute	acute	_	_	_	_	_	_	_
76	episode	episode	_	_	_	_	_	_	_
77	.	.	_	_	_	_	_	_	_

